title: [Immunotherapeutic treatment for metastatic renal carcinoma].
abstract: Immunotherapy management for advanced renal carcinoma has awaken a growing interest over the last few years. Based on Atzpodien's studies, in December 1994 a protocol was initiated in our centre for the treatment of metastatic renal carcinoma, using subcutaneous alpha interferon, subcutaneous Interleukin-2 and endovenous 5-Fluorouracil. The present report analyzes all six cases included in the protocol and their results.
authors.affiliation: Servicio de Urología, Hospital Son Dureta, Palma de Mallorca.
authors.forename: F
authors.initials: F
authors.lastname: Hidalgo Pardo
authors.forename: C
authors.initials: C
authors.lastname: Gutiérrez Sanz-Gadea
authors.forename: M J
authors.initials: MJ
authors.lastname: Rebassa Llull
authors.forename: J M
authors.initials: JM
authors.lastname: García Bueno
authors.forename: A
authors.initials: A
authors.lastname: Mus Malleu
authors.forename: G P
authors.initials: GP
authors.lastname: Losada González
authors.forename: M
authors.initials: M
authors.lastname: Ozonas Moragues
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000556:secondary / Q000628:therapy*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007167:Immunotherapy; D016898:Interferon-alpha / Q000008:administration & dosage; D007376:Interleukin-2 / Q000008:administration & dosage; D007680:Kidney Neoplasms / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged
chemical_list: D016898:Interferon-alpha; D007376:Interleukin-2; D005472:Fluorouracil
vernacular_title: Tratamiento inmunoterápico para el carcinoma renal metastásico.